Business
NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September
NAARDEN, The Netherlands and MIAMI, Aug. 25, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a
About this update from Newamsterdam Pharma Company N.v.
[{"type":"text","content":"NAARDEN, The Netherlands and MIAMI, Aug. 25, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that it will present additional pooled safety and efficacy data from the pivotal Phase 3 BROADWAY and BROOKLYN trials at the European Society of Cardiology Congress (ESC), taking place August 29 – September 1, 2025 in Madrid, Spain. Additionally, NewAmsterdam announced that company management will participate in three upcoming investor conferences. Details are as follows: European Society of Cardiology Congress (ESC) 2025 Presentation Title: Efficacy of obicetrapib across the spectrum of background lipid lowering therapies-pooled analyses of the Broadway and Brooklyn randomized trialsSession Title: Changing face of lipid-lowering therapyPresentation Date and Time: Friday, August 29, 2025 at 10:10am CESTPresenter: Kausik Ray, M.D. Presentation Title: Obicetrapib and cardiovascular eventsSession Title: Late-Breaking Clinical Science: lipids and cardiovascular riskPresentation Date and Time: Monday, September 1, 2025 at 9:00am CESTPresenter: Stephen Nicholls, M.D. Citi’s 2025 Biopharma Back to School Summit Fireside Chat Date and Time: Wednesday, September 3, 2025 at 2:30pm ET in Boston, MAPresenters: Michael Davidson, M.D., Chief Executive Officer, and Ian Somaiya, Chief Financial Officer Cantor Global Healthcare Conference 2025 Fireside Chat Date and Time: Thursday, September 4, 2025 at 2:45pm ET in New York, NYPresenters: Michael Davidson, M.D., Chief Executive Officer, and Ian Somaiya, Chief Financial Officer Wells Fargo Healthcare Conference Fireside Chat Date and Time: Friday, September 5, 2025 at 10:15am ET in Boston, MAPresenter: Ian Somaiya, Chief Financial Officer Live webcasts of the fireside chat presentations will be available through the investor relations section of the NewAmsterdam Pharma website at ir.newamsterdampharma.com. Following the live webcasts, archived replays will be available on the Company’s website. About NewAmsterdam NewAmsterdam Pharma (Nasdaq: NAMS) is a l...